142 related articles for article (PubMed ID: 7642332)
1. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases.
Stödtler M; Mietz H; Wiedemann P; Heimann K
Int Ophthalmol; 1994-1995; 18(6):323-8. PubMed ID: 7642332
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of cellular proliferation in eyes with longstanding retinal detachment.
Mietz H; Stödtler M; Wiedemann P; Heimann K
Int Ophthalmol; 1994-1995; 18(6):329-37. PubMed ID: 7642333
[TBL] [Abstract][Full Text] [Related]
3. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
[TBL] [Abstract][Full Text] [Related]
4. [Cytological study of subretinal fluid].
Xu X; He Z
Zhonghua Yan Ke Za Zhi; 1997 Nov; 33(6):450-2. PubMed ID: 10680550
[TBL] [Abstract][Full Text] [Related]
5. [Morphological features of vitreoretinal proliferation, complicating dystrophic retinal detachment and experimental models].
Balashova LM; Evgrafov VIu
Vestn Oftalmol; 1995; 111(2):37-9. PubMed ID: 7645179
[No Abstract] [Full Text] [Related]
6. Proliferation of the ciliary epithelium with retinal neuronal and photoreceptor cell differentiation in human eyes with retinal detachment and proliferative vitreoretinopathy.
Ducournau Y; Boscher C; Adelman RA; Guillaubey C; Schmidt-Morand D; Mosnier JF; Ducournau D
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):409-23. PubMed ID: 21932075
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
8. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy.
Charteris DG; Downie J; Aylward GW; Sethi C; Luthert P
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):93-100. PubMed ID: 16612635
[TBL] [Abstract][Full Text] [Related]
9. Morphological and pathogenetic aspects of proliferative vitreo-retinopathy. A histological and immunohistochemical study.
Toti P; Greco G; Catella AM
Doc Ophthalmol; 1994; 88(2):105-12. PubMed ID: 7781478
[TBL] [Abstract][Full Text] [Related]
10. Anterior proliferative vitreoretinopathy in trauma and complicated retinal detachment. A histopathologic study.
Mietz H; Kirchhof B; Heimann K
Ger J Ophthalmol; 1994 Jan; 3(1):15-8. PubMed ID: 8142875
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of intraocular silicone oil: retina and epiretinal membranes.
Wickham LJ; Asaria RH; Alexander R; Luthert P; Charteris DG
Br J Ophthalmol; 2007 Feb; 91(2):258-62. PubMed ID: 17005544
[TBL] [Abstract][Full Text] [Related]
12. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
[TBL] [Abstract][Full Text] [Related]
13. Anterior proliferative vitreoretinopathy. Clinicopathologic, light microscopic, and ultrastructural findings.
Elner SG; Elner VM; Díaz-Rohena R; Freeman HM; Tolentino FI; Albert DM
Ophthalmology; 1988 Oct; 95(10):1349-57. PubMed ID: 3226683
[TBL] [Abstract][Full Text] [Related]
14. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
[TBL] [Abstract][Full Text] [Related]
15. TRAUMATIC PROLIFERATIVE VITREORETINOPATHY: Clinical and Histopathological Observations.
Jin Y; Chen H; Xu X; Hu Y; Wang C; Ma Z
Retina; 2017 Jul; 37(7):1236-1245. PubMed ID: 27779559
[TBL] [Abstract][Full Text] [Related]
16. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
17. [Vitreoretinal proliferation as a cause of tractional retinal ablation after severe perforating injury].
Vicić D; Smiljanić N; Golijanin-Zaklan T; Aleksić P; Tanjga S
Vojnosanit Pregl; 1995; 52(1):12-7. PubMed ID: 7638944
[TBL] [Abstract][Full Text] [Related]
18. Vascular leakage stimulates phenotype alteration in ocular cells, contributing to the pathology of proliferative vitreoretinopathy.
Shiels IA; Zhang S; Ambler J; Taylor SM
Med Hypotheses; 1998 Feb; 50(2):113-7. PubMed ID: 9572564
[TBL] [Abstract][Full Text] [Related]
19. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study.
Tang S; Scheiffarth OF; Wildner G; Thurau SR; Lund OE
Ger J Ophthalmol; 1992; 1(3-4):176-9. PubMed ID: 1483132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
